The California Cardiac Surgery and Intervention Project: evolution of a public reporting program

Joseph S Carey1, Beate Danielsen, Forrest L Junod

  • 1California Society of Thoracic Surgeons, Torrance, USA.

The American Surgeon
|October 25, 2006
PubMed

Insights

California

Area of Science:

  • Cardiovascular Surgery
  • Health Policy
  • Public Health

Background:

  • Mandatory public reporting of cardiac surgery outcomes began in California in 2003.
  • Previous outcomes data were analyzed to assess the impact of this policy.

Purpose of the Study:

  • To evaluate the effect of mandatory public reporting on cardiac surgery outcomes in California.
  • To analyze changes in mortality rates and procedural volumes post-policy implementation.

Main Methods:

  • Utilized the Patient Discharge Database (PDD) to compare outcomes before (1998-2002) and after (2003-2004) the policy.
  • Risk-adjusted in-hospital mortality and procedural volumes for coronary artery bypass graft (CABG), valve, and percutaneous coronary intervention (PCI) were analyzed.
  • Included 30-day posthospital outcomes (death or reoperation) to identify outlier status.

Main Results:

  • Risk-adjusted in-hospital mortality decreased for CABG and valve procedures.
  • PCI mortality remained unchanged, while procedural volumes for PCI increased.
  • Average annual procedural volumes for CABG and overall cardiac surgery decreased.
  • Higher CABG mortality was noted in low-volume programs, though not statistically significant.

Conclusions:

  • The introduction of mandatory public reporting in California was associated with improved cardiac surgery outcomes.
  • The policy facilitated the identification of outlier programs using both in-hospital and 30-day posthospital data.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...